MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Momenta Pharmaceuticals Company Profile (NASDAQ:MNTA)

Consensus Ratings for Momenta Pharmaceuticals (NASDAQ:MNTA) (?)
Ratings Breakdown: 4 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $20.56 (116.15% upside)

Analysts' Ratings History for Momenta Pharmaceuticals (NASDAQ:MNTA)
Show:
DateFirmActionRatingPrice TargetActions
2/23/2016Cowen and CompanyLower Price Target$20.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Leerink SwannLower Price TargetOutperform$22.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016JPMorgan Chase & Co.Lower Price TargetOverweight$26.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Brean CapitalReiterated RatingBuy$29.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Stifel NicolausLower Price TargetBuy$29.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2016Maxim GroupReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/23/2015BarclaysInitiated CoverageEqual Weight$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/24/2015Sanford C. BernsteinReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Goldman SachsDowngradeBuy -> Neutral$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Bank of AmericaUpgradeUnderperform -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Canaccord GenuityReiterated RatingBuy$22.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 4/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha